Overview
Early onset dysthymia, often considered within the context of early onset sepsis (EOS) in neonates, refers to persistent depressive symptoms emerging shortly after birth, though the provided abstracts focus more on the clinical management of EOS rather than dysthymia specifically. The primary clinical focus here pertains to the identification and management of EOS, which can indirectly relate to neonatal mood and developmental outcomes 12.Diagnosis
Clinical Signs: Monitor for signs of septic shock and other clinical indicators of infection.
Biomarkers: Evaluate maternal, cord blood, and neonatal serum biomarkers for improved diagnostic accuracy 2.
Risk Factors: Assess neonates for risk factors including gestational age, exposure to Group B Streptococcus (GBS), and Escherichia coli (E. coli) 1.
Serial Examinations: Conduct regular physical examinations in neonates at risk for EOS 1.Management
Immediate Antibiotics: Administer amoxicillin combined with an aminoglycoside for empirical treatment in suspected EOS 1.
Avoid Unnecessary Treatment: Do not treat neonates without clinical signs suggestive of EOS with antibiotics 1.
Targeted Pathogens: Focus empirical treatment on leading pathogens such as GBS and E. coli 1.Special Populations
Neonates: Specific guidelines apply, emphasizing risk stratification and judicious use of antibiotics 1.
Prematurity: Higher incidence and mortality rates noted in very preterm infants, requiring more vigilant monitoring and management 1.Key Recommendations
Administer antibiotics immediately in neonates presenting with clinical signs of septic shock (Evidence: Strong 1).
Avoid empirical antibiotic treatment in neonates without clinical signs of EOS (Evidence: Strong 1).
Use amoxicillin combined with an aminoglycoside as first-line empirical therapy for EOS (Evidence: Strong 1).
Regularly monitor neonates at risk for EOS through serial physical examinations (Evidence: Moderate 1).
Consider biomarker assessments in maternal and neonatal samples to improve diagnostic accuracy (Evidence: Moderate 2).References
1 Stocker M, Rosa-Mangeret F, Agyeman PKA, McDougall J, Berger C, Giannoni E. Management of neonates at risk of early onset sepsis: a probability-based approach and recent literature appraisal : Update of the Swiss national guideline of the Swiss Society of Neonatology and the Pediatric Infectious Disease Group Switzerland. European journal of pediatrics 2024. link
2 van Leeuwen LM, Fourie E, van den Brink G, Bekker V, van Houten MA. Diagnostic value of maternal, cord blood and neonatal biomarkers for early-onset sepsis: a systematic review and meta-analysis. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 2024. link